Leukotriene Receptor Antagonists

Marzena E. Krawiec; Nizar J. Jarjour

doi:10.1055/s-2003-39023

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2003; 24(2): 229-230
DOI: 10.1055/s-2003-39023

ERRATA

Leukotriene Receptor Antagonists

Marzena E. Krawiec¹ , Nizar J. Jarjour²

¹Department of Pediatrics, University of Wisconsin, Madison, Wisconsin
²Department of Medicine, University of Wisconsin, Madison, Wisconsin

Abstract

Full Text

PDF Download

The publisher regrets an error in a statement in the above article in Seminars in Respiratory and Critical Care Medicine, volume 23, number 4, p. 403. Column 1, paragraph 1. A sentence states: "Furthermore, urinary excretion of LTE₄ was significantly increased in the montelukast group (34.4 to 73.7 pg/mg creatinine; p < 0.05) compared with placebo." It should say: "Furthermore, urinary excretion of LTE4 was significantly increased after exercise (34.4 to 73.7 pg/mg creatinine; p < 0.05)."